XI’AN, CHINA -- (MARKET WIRE) -- November 09, 2006 -- Skystar Bio-Pharmaceutical (OTCBB: SKBI), a leading bio-pharmaceutical company in China, today announced that it has retained Nexus Investor Relations to lead an expanded shareholder communication program.
